Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	View
JYSB2300180	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2023-10-26				view
JYSB2200145	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2022-08-08		Bayer Healthcare LLC		view
JYSB2400158	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-07-16				view
CYSB2200011	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products(原10)	Supplementary Application	2022-01-10		SinoCelltech Ltd		view
JYSB2200094	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2022-06-09				view
JXSS2200002	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products(3.1)	Import Drug Application	2022-01-26				view
JYSB2101172	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2021-11-25				view
CXSB2400122	注射用重组人凝血因子Ⅷ-Fc融合蛋白	Recombinant Human Coagulation Factor VIII-Fc Fusion Protein	Lyophilized	Biological Products(2.4)	Supplementary Application	2024-10-13		Chengdu Rongsheng Pharmaceuticals Co Ltd		view
JYSB2101027	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2021-05-12		Bayer Healthcare LLC		view
JYSB2300034	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2023-02-23		Bayer Healthcare LLC		view
JYSB2101161	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2021-11-10				view
JYSB2400050	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-03-07				view
JYSB1200214	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2012-08-27	拜耳医药保健有限公司	Bayer Healthcare Company Ltd	Approval Completed-Pending Certificated	view
JYSB2101170	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2021-11-25				view
JTS2200033	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Disposable Import Drug Application	2022-05-28				view
CYSB2400087	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products(3.4)	Supplementary Application	2024-04-09		Chengdu Rongsheng Pharmaceuticals Co Ltd		view
JYSB2101169	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2021-11-25				view
JTS2200019	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Disposable Import Drug Application	2022-04-20				view
JYSB2400155	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-07-16				view
JYSZ2100535	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	License Renew	2021-12-17				view